Shares of Severn Trent PLC (OTCMKTS:STRNY – Get Free Report) have been given a consensus recommendation of “Hold” by the six analysts that are currently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating.
Several analysts have recently commented on STRNY shares. BNP Paribas Exane started coverage on Severn Trent in a report on Monday, June 29th. They issued a “neutral” rating for the company. Zacks Research raised Severn Trent from a “strong sell” rating to a “hold” rating in a report on Friday, June 12th. Royal Bank Of Canada reiterated a “sector perform” rating on shares of Severn Trent in a research report on Monday, June 1st. Jefferies Financial Group downgraded Severn Trent from a “strong-buy” rating to a “hold” rating in a report on Monday, August 3rd. Finally, Citigroup restated a “neutral” rating on shares of Severn Trent in a research report on Thursday, June 11th.
Read Our Latest Research Report on STRNY
Severn Trent Stock Performance
Severn Trent Company Profile
Severn Trent Plc (OTCMKTS:STRNY) is an integrated water utility company based in Coventry, United Kingdom, specializing in the provision of water supply and wastewater treatment services. As one of the principal regulated water and sewerage companies in England and Wales, it delivers clean drinking water to households and businesses, manages sewer networks, operates sewage treatment works, and maintains extensive water infrastructure across its service regions. Its operations are governed by regulatory frameworks that aim to ensure high standards of water quality, environmental protection, and customer service.
The company traces its origins to the privatization of the regional water authorities in England and Wales in 1989.
Further Reading
- Five stocks we like better than Severn Trent
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Severn Trent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Severn Trent and related companies with MarketBeat.com's FREE daily email newsletter.
